Children differ from adults in many aspects of pharmacotherapy, including capabilities for drug administration, medicine-related toxicity, and taste preferences. It is essential that pediatric medicines are formulated to best suit a child's age, size, physiologic condition, and treatment requirements. Therefore, the pediatric drug and vasccines specially serve for children.
The global Pediatric Drugs and Vaccines market size is projected to reach US$ 176440 million by 2027, from US$ 104980 million in 2020, at a CAGR of 9.0% during 2022-2027.
The global Pediatric Drugs and Vaccines market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pediatric Drugs and Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Geographical Analysis:
Based on region, the global Pediatric Drugs and Vaccines market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Pediatric Drugs and Vaccines market are
Merck & Co., Inc. (USA)
Abbott Laboratories (USA)
Amgen, Inc. (USA)
Eli Lilly and Company (USA)
F. Hoffmann-La Roche Ltd (Switzerland)
Genentech, Inc. (USA)
GlaxoSmithKline plc. (UK)
Janssen Biologics B.V. (USA)
Actelion Pharmaceuticals
AstraZeneca Plc. (UK)
Boehringer Ingelheim GmbH (Germany)
Bristol-Myers Squibb Company (USA)
Allergan, Inc. (USA)
Novartis AG (Switzerland)
Novo Nordisk A/S (Denmark)
Pfizer, Inc. (USA)
Sanofi S.A (France)
Shionogi Inc. (USA)
Takeda
Segment by Type
Diphtheria
Influenza
Hepatitis
Pneumococcal Diseases
Meningococcal Diseases
Mumps
Others
Segment by Application
Newborn
Infant
Child
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Pediatric Drugs and Vaccines market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Pediatric Drugs and Vaccines market.
• The market share of the global Pediatric Drugs and Vaccines market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Pediatric Drugs and Vaccines market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Pediatric Drugs and Vaccines market.
The global Pediatric Drugs and Vaccines market size is projected to reach US$ 176440 million by 2027, from US$ 104980 million in 2020, at a CAGR of 9.0% during 2022-2027.
The global Pediatric Drugs and Vaccines market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pediatric Drugs and Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Geographical Analysis:
Based on region, the global Pediatric Drugs and Vaccines market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Pediatric Drugs and Vaccines market are
Merck & Co., Inc. (USA)
Abbott Laboratories (USA)
Amgen, Inc. (USA)
Eli Lilly and Company (USA)
F. Hoffmann-La Roche Ltd (Switzerland)
Genentech, Inc. (USA)
GlaxoSmithKline plc. (UK)
Janssen Biologics B.V. (USA)
Actelion Pharmaceuticals
AstraZeneca Plc. (UK)
Boehringer Ingelheim GmbH (Germany)
Bristol-Myers Squibb Company (USA)
Allergan, Inc. (USA)
Novartis AG (Switzerland)
Novo Nordisk A/S (Denmark)
Pfizer, Inc. (USA)
Sanofi S.A (France)
Shionogi Inc. (USA)
Takeda
Segment by Type
Diphtheria
Influenza
Hepatitis
Pneumococcal Diseases
Meningococcal Diseases
Mumps
Others
Segment by Application
Newborn
Infant
Child
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Pediatric Drugs and Vaccines market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Pediatric Drugs and Vaccines market.
• The market share of the global Pediatric Drugs and Vaccines market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Pediatric Drugs and Vaccines market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Pediatric Drugs and Vaccines market.
1 Pediatric Drugs and Vaccines Market Overview
1.1 Pediatric Drugs and Vaccines Product Scope
1.2 Pediatric Drugs and Vaccines Segment by Type
1.2.1 Global Pediatric Drugs and Vaccines Sales by Type (2016 & 2021 & 2027)
1.2.2 Diphtheria
1.2.3 Influenza
1.2.4 Hepatitis
1.2.5 Pneumococcal Diseases
1.2.6 Meningococcal Diseases
1.2.7 Mumps
1.2.8 Others
1.3 Pediatric Drugs and Vaccines Segment by Application
1.3.1 Global Pediatric Drugs and Vaccines Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Newborn
1.3.3 Infant
1.3.4 Child
1.4 Pediatric Drugs and Vaccines Market Estimates and Forecasts (2016-2027)
1.4.1 Global Pediatric Drugs and Vaccines Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Pediatric Drugs and Vaccines Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Pediatric Drugs and Vaccines Price Trends (2016-2027)
2 Pediatric Drugs and Vaccines Estimates and Forecasts by Region
2.1 Global Pediatric Drugs and Vaccines Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Pediatric Drugs and Vaccines Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Pediatric Drugs and Vaccines Sales Market Share by Region (2016-2021)
2.2.2 Global Pediatric Drugs and Vaccines Revenue Market Share by Region (2016-2021)
2.3 Global Pediatric Drugs and Vaccines Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Pediatric Drugs and Vaccines Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Pediatric Drugs and Vaccines Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Pediatric Drugs and Vaccines Estimates and Projections (2016-2027)
2.4.2 Europe Pediatric Drugs and Vaccines Estimates and Projections (2016-2027)
2.4.3 China Pediatric Drugs and Vaccines Estimates and Projections (2016-2027)
2.4.4 Japan Pediatric Drugs and Vaccines Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Pediatric Drugs and Vaccines Estimates and Projections (2016-2027)
2.4.6 India Pediatric Drugs and Vaccines Estimates and Projections (2016-2027)
3 Global Pediatric Drugs and Vaccines Competition Landscape by Players
3.1 Global Top Pediatric Drugs and Vaccines Players by Sales (2016-2021)
3.2 Global Top Pediatric Drugs and Vaccines Players by Revenue (2016-2021)
3.3 Global Pediatric Drugs and Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pediatric Drugs and Vaccines as of 2020)
3.4 Global Pediatric Drugs and Vaccines Average Price by Company (2016-2021)
3.5 Manufacturers Pediatric Drugs and Vaccines Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Pediatric Drugs and Vaccines Market Size by Type
4.1 Global Pediatric Drugs and Vaccines Historic Market Review by Type (2016-2021)
4.1.1 Global Pediatric Drugs and Vaccines Sales Market Share by Type (2016-2021)
4.1.2 Global Pediatric Drugs and Vaccines Revenue Market Share by Type (2016-2021)
4.1.3 Global Pediatric Drugs and Vaccines Price by Type (2016-2021)
4.2 Global Pediatric Drugs and Vaccines Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Pediatric Drugs and Vaccines Sales Forecast by Type (2022-2027)
4.2.2 Global Pediatric Drugs and Vaccines Revenue Forecast by Type (2022-2027)
4.2.3 Global Pediatric Drugs and Vaccines Price Forecast by Type (2022-2027)
5 Global Pediatric Drugs and Vaccines Market Size by Application
5.1 Global Pediatric Drugs and Vaccines Historic Market Review by Application (2016-2021)
5.1.1 Global Pediatric Drugs and Vaccines Sales Market Share by Application (2016-2021)
5.1.2 Global Pediatric Drugs and Vaccines Revenue Market Share by Application (2016-2021)
5.1.3 Global Pediatric Drugs and Vaccines Price by Application (2016-2021)
5.2 Global Pediatric Drugs and Vaccines Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Pediatric Drugs and Vaccines Sales Forecast by Application (2022-2027)
5.2.2 Global Pediatric Drugs and Vaccines Revenue Forecast by Application (2022-2027)
5.2.3 Global Pediatric Drugs and Vaccines Price Forecast by Application (2022-2027)
6 North America Pediatric Drugs and Vaccines Market Facts & Figures
6.1 North America Pediatric Drugs and Vaccines Sales by Company
6.1.1 North America Pediatric Drugs and Vaccines Sales by Company (2016-2021)
6.1.2 North America Pediatric Drugs and Vaccines Revenue by Company (2016-2021)
6.2 North America Pediatric Drugs and Vaccines Sales Breakdown by Type
6.2.1 North America Pediatric Drugs and Vaccines Sales Breakdown by Type (2016-2021)
6.2.2 North America Pediatric Drugs and Vaccines Sales Breakdown by Type (2022-2027)
6.3 North America Pediatric Drugs and Vaccines Sales Breakdown by Application
6.3.1 North America Pediatric Drugs and Vaccines Sales Breakdown by Application (2016-2021)
6.3.2 North America Pediatric Drugs and Vaccines Sales Breakdown by Application (2022-2027)
7 Europe Pediatric Drugs and Vaccines Market Facts & Figures
7.1 Europe Pediatric Drugs and Vaccines Sales by Company
7.1.1 Europe Pediatric Drugs and Vaccines Sales by Company (2016-2021)
7.1.2 Europe Pediatric Drugs and Vaccines Revenue by Company (2016-2021)
7.2 Europe Pediatric Drugs and Vaccines Sales Breakdown by Type
7.2.1 Europe Pediatric Drugs and Vaccines Sales Breakdown by Type (2016-2021)
7.2.2 Europe Pediatric Drugs and Vaccines Sales Breakdown by Type (2022-2027)
7.3 Europe Pediatric Drugs and Vaccines Sales Breakdown by Application
7.3.1 Europe 143 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 143 Sales Breakdown by Application (2022-2027)
8 China Pediatric Drugs and Vaccines Market Facts & Figures
8.1 China Pediatric Drugs and Vaccines Sales by Company
8.1.1 China Pediatric Drugs and Vaccines Sales by Company (2016-2021)
8.1.2 China Pediatric Drugs and Vaccines Revenue by Company (2016-2021)
8.2 China Pediatric Drugs and Vaccines Sales Breakdown by Type
8.2.1 China Pediatric Drugs and Vaccines Sales Breakdown by Type (2016-2021)
8.2.2 China Pediatric Drugs and Vaccines Sales Breakdown by Type (2022-2027)
8.3 China Pediatric Drugs and Vaccines Sales Breakdown by Application
8.3.1 China 163 Sales Breakdown by Application (2016-2021)
8.3.2 China 163 Sales Breakdown by Application (2022-2027)
9 Japan Pediatric Drugs and Vaccines Market Facts & Figures
9.1 Japan Pediatric Drugs and Vaccines Sales by Company
9.1.1 Japan Pediatric Drugs and Vaccines Sales by Company (2016-2021)
9.1.2 Japan Pediatric Drugs and Vaccines Revenue by Company (2016-2021)
9.2 Japan Pediatric Drugs and Vaccines Sales Breakdown by Type
9.2.1 Japan Pediatric Drugs and Vaccines Sales Breakdown by Type (2016-2021)
9.2.2 Japan Pediatric Drugs and Vaccines Sales Breakdown by Type (2022-2027)
9.3 Japan Pediatric Drugs and Vaccines Sales Breakdown by Application
9.3.1 Japan Mar. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Mar. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Pediatric Drugs and Vaccines Market Facts & Figures
10.1 Southeast Asia Pediatric Drugs and Vaccines Sales by Company
10.1.1 Southeast Asia Pediatric Drugs and Vaccines Sales by Company (2016-2021)
10.1.2 Southeast Asia Pediatric Drugs and Vaccines Revenue by Company (2016-2021)
10.2 Southeast Asia Pediatric Drugs and Vaccines Sales Breakdown by Type
10.2.1 Southeast Asia Pediatric Drugs and Vaccines Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Pediatric Drugs and Vaccines Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Pediatric Drugs and Vaccines Sales Breakdown by Application
10.3.1 Southeast Asia Kg Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia Kg Sales Breakdown by Application (2022-2027)
11 India Pediatric Drugs and Vaccines Market Facts & Figures
11.1 India Pediatric Drugs and Vaccines Sales by Company
11.1.1 India Pediatric Drugs and Vaccines Sales by Company (2016-2021)
11.1.2 India Pediatric Drugs and Vaccines Revenue by Company (2016-2021)
11.2 India Pediatric Drugs and Vaccines Sales Breakdown by Type
11.2.1 India Pediatric Drugs and Vaccines Sales Breakdown by Type (2016-2021)
11.2.2 India Pediatric Drugs and Vaccines Sales Breakdown by Type (2022-2027)
11.3 India Pediatric Drugs and Vaccines Sales Breakdown by Application
11.3.1 India Pediatric Drugs and Vaccines Sales Breakdown by Application (2016-2021)
11.3.2 India Pediatric Drugs and Vaccines Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Pediatric Drugs and Vaccines Business
12.1 Merck & Co., Inc. (USA)
12.1.1 Merck & Co., Inc. (USA) Corporation Information
12.1.2 Merck & Co., Inc. (USA) Business Overview
12.1.3 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Products Offered
12.1.5 Merck & Co., Inc. (USA) Recent Development
12.2 Abbott Laboratories (USA)
12.2.1 Abbott Laboratories (USA) Corporation Information
12.2.2 Abbott Laboratories (USA) Business Overview
12.2.3 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Products Offered
12.2.5 Abbott Laboratories (USA) Recent Development
12.3 Amgen, Inc. (USA)
12.3.1 Amgen, Inc. (USA) Corporation Information
12.3.2 Amgen, Inc. (USA) Business Overview
12.3.3 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Products Offered
12.3.5 Amgen, Inc. (USA) Recent Development
12.4 Eli Lilly and Company (USA)
12.4.1 Eli Lilly and Company (USA) Corporation Information
12.4.2 Eli Lilly and Company (USA) Business Overview
12.4.3 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Products Offered
12.4.5 Eli Lilly and Company (USA) Recent Development
12.5 F. Hoffmann-La Roche Ltd (Switzerland)
12.5.1 F. Hoffmann-La Roche Ltd (Switzerland) Corporation Information
12.5.2 F. Hoffmann-La Roche Ltd (Switzerland) Business Overview
12.5.3 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.5.4 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Products Offered
12.5.5 F. Hoffmann-La Roche Ltd (Switzerland) Recent Development
12.6 Genentech, Inc. (USA)
12.6.1 Genentech, Inc. (USA) Corporation Information
12.6.2 Genentech, Inc. (USA) Business Overview
12.6.3 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Products Offered
12.6.5 Genentech, Inc. (USA) Recent Development
12.7 GlaxoSmithKline plc. (UK)
12.7.1 GlaxoSmithKline plc. (UK) Corporation Information
12.7.2 GlaxoSmithKline plc. (UK) Business Overview
12.7.3 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.7.4 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Products Offered
12.7.5 GlaxoSmithKline plc. (UK) Recent Development
12.8 Janssen Biologics B.V. (USA)
12.8.1 Janssen Biologics B.V. (USA) Corporation Information
12.8.2 Janssen Biologics B.V. (USA) Business Overview
12.8.3 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Products Offered
12.8.5 Janssen Biologics B.V. (USA) Recent Development
12.9 Actelion Pharmaceuticals
12.9.1 Actelion Pharmaceuticals Corporation Information
12.9.2 Actelion Pharmaceuticals Business Overview
12.9.3 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Products Offered
12.9.5 Actelion Pharmaceuticals Recent Development
12.10 AstraZeneca Plc. (UK)
12.10.1 AstraZeneca Plc. (UK) Corporation Information
12.10.2 AstraZeneca Plc. (UK) Business Overview
12.10.3 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.10.4 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Products Offered
12.10.5 AstraZeneca Plc. (UK) Recent Development
12.11 Boehringer Ingelheim GmbH (Germany)
12.11.1 Boehringer Ingelheim GmbH (Germany) Corporation Information
12.11.2 Boehringer Ingelheim GmbH (Germany) Business Overview
12.11.3 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Products Offered
12.11.5 Boehringer Ingelheim GmbH (Germany) Recent Development
12.12 Bristol-Myers Squibb Company (USA)
12.12.1 Bristol-Myers Squibb Company (USA) Corporation Information
12.12.2 Bristol-Myers Squibb Company (USA) Business Overview
12.12.3 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Products Offered
12.12.5 Bristol-Myers Squibb Company (USA) Recent Development
12.13 Allergan, Inc. (USA)
12.13.1 Allergan, Inc. (USA) Corporation Information
12.13.2 Allergan, Inc. (USA) Business Overview
12.13.3 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Products Offered
12.13.5 Allergan, Inc. (USA) Recent Development
12.14 Novartis AG (Switzerland)
12.14.1 Novartis AG (Switzerland) Corporation Information
12.14.2 Novartis AG (Switzerland) Business Overview
12.14.3 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Products Offered
12.14.5 Novartis AG (Switzerland) Recent Development
12.15 Novo Nordisk A/S (Denmark)
12.15.1 Novo Nordisk A/S (Denmark) Corporation Information
12.15.2 Novo Nordisk A/S (Denmark) Business Overview
12.15.3 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Products Offered
12.15.5 Novo Nordisk A/S (Denmark) Recent Development
12.16 Pfizer, Inc. (USA)
12.16.1 Pfizer, Inc. (USA) Corporation Information
12.16.2 Pfizer, Inc. (USA) Business Overview
12.16.3 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Products Offered
12.16.5 Pfizer, Inc. (USA) Recent Development
12.17 Sanofi S.A (France)
12.17.1 Sanofi S.A (France) Corporation Information
12.17.2 Sanofi S.A (France) Business Overview
12.17.3 Sanofi S.A (France) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Sanofi S.A (France) Pediatric Drugs and Vaccines Products Offered
12.17.5 Sanofi S.A (France) Recent Development
12.18 Shionogi Inc. (USA)
12.18.1 Shionogi Inc. (USA) Corporation Information
12.18.2 Shionogi Inc. (USA) Business Overview
12.18.3 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Products Offered
12.18.5 Shionogi Inc. (USA) Recent Development
12.19 Takeda
12.19.1 Takeda Corporation Information
12.19.2 Takeda Business Overview
12.19.3 Takeda Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Takeda Pediatric Drugs and Vaccines Products Offered
12.19.5 Takeda Recent Development
13 Pediatric Drugs and Vaccines Manufacturing Cost Analysis
13.1 Pediatric Drugs and Vaccines Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Pediatric Drugs and Vaccines
13.4 Pediatric Drugs and Vaccines Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Pediatric Drugs and Vaccines Distributors List
14.3 Pediatric Drugs and Vaccines Customers
15 Market Dynamics
15.1 Pediatric Drugs and Vaccines Market Trends
15.2 Pediatric Drugs and Vaccines Drivers
15.3 Pediatric Drugs and Vaccines Market Challenges
15.4 Pediatric Drugs and Vaccines Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
1.1 Pediatric Drugs and Vaccines Product Scope
1.2 Pediatric Drugs and Vaccines Segment by Type
1.2.1 Global Pediatric Drugs and Vaccines Sales by Type (2016 & 2021 & 2027)
1.2.2 Diphtheria
1.2.3 Influenza
1.2.4 Hepatitis
1.2.5 Pneumococcal Diseases
1.2.6 Meningococcal Diseases
1.2.7 Mumps
1.2.8 Others
1.3 Pediatric Drugs and Vaccines Segment by Application
1.3.1 Global Pediatric Drugs and Vaccines Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Newborn
1.3.3 Infant
1.3.4 Child
1.4 Pediatric Drugs and Vaccines Market Estimates and Forecasts (2016-2027)
1.4.1 Global Pediatric Drugs and Vaccines Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Pediatric Drugs and Vaccines Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Pediatric Drugs and Vaccines Price Trends (2016-2027)
2 Pediatric Drugs and Vaccines Estimates and Forecasts by Region
2.1 Global Pediatric Drugs and Vaccines Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Pediatric Drugs and Vaccines Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Pediatric Drugs and Vaccines Sales Market Share by Region (2016-2021)
2.2.2 Global Pediatric Drugs and Vaccines Revenue Market Share by Region (2016-2021)
2.3 Global Pediatric Drugs and Vaccines Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Pediatric Drugs and Vaccines Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Pediatric Drugs and Vaccines Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Pediatric Drugs and Vaccines Estimates and Projections (2016-2027)
2.4.2 Europe Pediatric Drugs and Vaccines Estimates and Projections (2016-2027)
2.4.3 China Pediatric Drugs and Vaccines Estimates and Projections (2016-2027)
2.4.4 Japan Pediatric Drugs and Vaccines Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Pediatric Drugs and Vaccines Estimates and Projections (2016-2027)
2.4.6 India Pediatric Drugs and Vaccines Estimates and Projections (2016-2027)
3 Global Pediatric Drugs and Vaccines Competition Landscape by Players
3.1 Global Top Pediatric Drugs and Vaccines Players by Sales (2016-2021)
3.2 Global Top Pediatric Drugs and Vaccines Players by Revenue (2016-2021)
3.3 Global Pediatric Drugs and Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pediatric Drugs and Vaccines as of 2020)
3.4 Global Pediatric Drugs and Vaccines Average Price by Company (2016-2021)
3.5 Manufacturers Pediatric Drugs and Vaccines Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Pediatric Drugs and Vaccines Market Size by Type
4.1 Global Pediatric Drugs and Vaccines Historic Market Review by Type (2016-2021)
4.1.1 Global Pediatric Drugs and Vaccines Sales Market Share by Type (2016-2021)
4.1.2 Global Pediatric Drugs and Vaccines Revenue Market Share by Type (2016-2021)
4.1.3 Global Pediatric Drugs and Vaccines Price by Type (2016-2021)
4.2 Global Pediatric Drugs and Vaccines Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Pediatric Drugs and Vaccines Sales Forecast by Type (2022-2027)
4.2.2 Global Pediatric Drugs and Vaccines Revenue Forecast by Type (2022-2027)
4.2.3 Global Pediatric Drugs and Vaccines Price Forecast by Type (2022-2027)
5 Global Pediatric Drugs and Vaccines Market Size by Application
5.1 Global Pediatric Drugs and Vaccines Historic Market Review by Application (2016-2021)
5.1.1 Global Pediatric Drugs and Vaccines Sales Market Share by Application (2016-2021)
5.1.2 Global Pediatric Drugs and Vaccines Revenue Market Share by Application (2016-2021)
5.1.3 Global Pediatric Drugs and Vaccines Price by Application (2016-2021)
5.2 Global Pediatric Drugs and Vaccines Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Pediatric Drugs and Vaccines Sales Forecast by Application (2022-2027)
5.2.2 Global Pediatric Drugs and Vaccines Revenue Forecast by Application (2022-2027)
5.2.3 Global Pediatric Drugs and Vaccines Price Forecast by Application (2022-2027)
6 North America Pediatric Drugs and Vaccines Market Facts & Figures
6.1 North America Pediatric Drugs and Vaccines Sales by Company
6.1.1 North America Pediatric Drugs and Vaccines Sales by Company (2016-2021)
6.1.2 North America Pediatric Drugs and Vaccines Revenue by Company (2016-2021)
6.2 North America Pediatric Drugs and Vaccines Sales Breakdown by Type
6.2.1 North America Pediatric Drugs and Vaccines Sales Breakdown by Type (2016-2021)
6.2.2 North America Pediatric Drugs and Vaccines Sales Breakdown by Type (2022-2027)
6.3 North America Pediatric Drugs and Vaccines Sales Breakdown by Application
6.3.1 North America Pediatric Drugs and Vaccines Sales Breakdown by Application (2016-2021)
6.3.2 North America Pediatric Drugs and Vaccines Sales Breakdown by Application (2022-2027)
7 Europe Pediatric Drugs and Vaccines Market Facts & Figures
7.1 Europe Pediatric Drugs and Vaccines Sales by Company
7.1.1 Europe Pediatric Drugs and Vaccines Sales by Company (2016-2021)
7.1.2 Europe Pediatric Drugs and Vaccines Revenue by Company (2016-2021)
7.2 Europe Pediatric Drugs and Vaccines Sales Breakdown by Type
7.2.1 Europe Pediatric Drugs and Vaccines Sales Breakdown by Type (2016-2021)
7.2.2 Europe Pediatric Drugs and Vaccines Sales Breakdown by Type (2022-2027)
7.3 Europe Pediatric Drugs and Vaccines Sales Breakdown by Application
7.3.1 Europe 143 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 143 Sales Breakdown by Application (2022-2027)
8 China Pediatric Drugs and Vaccines Market Facts & Figures
8.1 China Pediatric Drugs and Vaccines Sales by Company
8.1.1 China Pediatric Drugs and Vaccines Sales by Company (2016-2021)
8.1.2 China Pediatric Drugs and Vaccines Revenue by Company (2016-2021)
8.2 China Pediatric Drugs and Vaccines Sales Breakdown by Type
8.2.1 China Pediatric Drugs and Vaccines Sales Breakdown by Type (2016-2021)
8.2.2 China Pediatric Drugs and Vaccines Sales Breakdown by Type (2022-2027)
8.3 China Pediatric Drugs and Vaccines Sales Breakdown by Application
8.3.1 China 163 Sales Breakdown by Application (2016-2021)
8.3.2 China 163 Sales Breakdown by Application (2022-2027)
9 Japan Pediatric Drugs and Vaccines Market Facts & Figures
9.1 Japan Pediatric Drugs and Vaccines Sales by Company
9.1.1 Japan Pediatric Drugs and Vaccines Sales by Company (2016-2021)
9.1.2 Japan Pediatric Drugs and Vaccines Revenue by Company (2016-2021)
9.2 Japan Pediatric Drugs and Vaccines Sales Breakdown by Type
9.2.1 Japan Pediatric Drugs and Vaccines Sales Breakdown by Type (2016-2021)
9.2.2 Japan Pediatric Drugs and Vaccines Sales Breakdown by Type (2022-2027)
9.3 Japan Pediatric Drugs and Vaccines Sales Breakdown by Application
9.3.1 Japan Mar. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Mar. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Pediatric Drugs and Vaccines Market Facts & Figures
10.1 Southeast Asia Pediatric Drugs and Vaccines Sales by Company
10.1.1 Southeast Asia Pediatric Drugs and Vaccines Sales by Company (2016-2021)
10.1.2 Southeast Asia Pediatric Drugs and Vaccines Revenue by Company (2016-2021)
10.2 Southeast Asia Pediatric Drugs and Vaccines Sales Breakdown by Type
10.2.1 Southeast Asia Pediatric Drugs and Vaccines Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Pediatric Drugs and Vaccines Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Pediatric Drugs and Vaccines Sales Breakdown by Application
10.3.1 Southeast Asia Kg Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia Kg Sales Breakdown by Application (2022-2027)
11 India Pediatric Drugs and Vaccines Market Facts & Figures
11.1 India Pediatric Drugs and Vaccines Sales by Company
11.1.1 India Pediatric Drugs and Vaccines Sales by Company (2016-2021)
11.1.2 India Pediatric Drugs and Vaccines Revenue by Company (2016-2021)
11.2 India Pediatric Drugs and Vaccines Sales Breakdown by Type
11.2.1 India Pediatric Drugs and Vaccines Sales Breakdown by Type (2016-2021)
11.2.2 India Pediatric Drugs and Vaccines Sales Breakdown by Type (2022-2027)
11.3 India Pediatric Drugs and Vaccines Sales Breakdown by Application
11.3.1 India Pediatric Drugs and Vaccines Sales Breakdown by Application (2016-2021)
11.3.2 India Pediatric Drugs and Vaccines Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Pediatric Drugs and Vaccines Business
12.1 Merck & Co., Inc. (USA)
12.1.1 Merck & Co., Inc. (USA) Corporation Information
12.1.2 Merck & Co., Inc. (USA) Business Overview
12.1.3 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Products Offered
12.1.5 Merck & Co., Inc. (USA) Recent Development
12.2 Abbott Laboratories (USA)
12.2.1 Abbott Laboratories (USA) Corporation Information
12.2.2 Abbott Laboratories (USA) Business Overview
12.2.3 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Products Offered
12.2.5 Abbott Laboratories (USA) Recent Development
12.3 Amgen, Inc. (USA)
12.3.1 Amgen, Inc. (USA) Corporation Information
12.3.2 Amgen, Inc. (USA) Business Overview
12.3.3 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Products Offered
12.3.5 Amgen, Inc. (USA) Recent Development
12.4 Eli Lilly and Company (USA)
12.4.1 Eli Lilly and Company (USA) Corporation Information
12.4.2 Eli Lilly and Company (USA) Business Overview
12.4.3 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Products Offered
12.4.5 Eli Lilly and Company (USA) Recent Development
12.5 F. Hoffmann-La Roche Ltd (Switzerland)
12.5.1 F. Hoffmann-La Roche Ltd (Switzerland) Corporation Information
12.5.2 F. Hoffmann-La Roche Ltd (Switzerland) Business Overview
12.5.3 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.5.4 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Products Offered
12.5.5 F. Hoffmann-La Roche Ltd (Switzerland) Recent Development
12.6 Genentech, Inc. (USA)
12.6.1 Genentech, Inc. (USA) Corporation Information
12.6.2 Genentech, Inc. (USA) Business Overview
12.6.3 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Products Offered
12.6.5 Genentech, Inc. (USA) Recent Development
12.7 GlaxoSmithKline plc. (UK)
12.7.1 GlaxoSmithKline plc. (UK) Corporation Information
12.7.2 GlaxoSmithKline plc. (UK) Business Overview
12.7.3 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.7.4 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Products Offered
12.7.5 GlaxoSmithKline plc. (UK) Recent Development
12.8 Janssen Biologics B.V. (USA)
12.8.1 Janssen Biologics B.V. (USA) Corporation Information
12.8.2 Janssen Biologics B.V. (USA) Business Overview
12.8.3 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Products Offered
12.8.5 Janssen Biologics B.V. (USA) Recent Development
12.9 Actelion Pharmaceuticals
12.9.1 Actelion Pharmaceuticals Corporation Information
12.9.2 Actelion Pharmaceuticals Business Overview
12.9.3 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Products Offered
12.9.5 Actelion Pharmaceuticals Recent Development
12.10 AstraZeneca Plc. (UK)
12.10.1 AstraZeneca Plc. (UK) Corporation Information
12.10.2 AstraZeneca Plc. (UK) Business Overview
12.10.3 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.10.4 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Products Offered
12.10.5 AstraZeneca Plc. (UK) Recent Development
12.11 Boehringer Ingelheim GmbH (Germany)
12.11.1 Boehringer Ingelheim GmbH (Germany) Corporation Information
12.11.2 Boehringer Ingelheim GmbH (Germany) Business Overview
12.11.3 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Products Offered
12.11.5 Boehringer Ingelheim GmbH (Germany) Recent Development
12.12 Bristol-Myers Squibb Company (USA)
12.12.1 Bristol-Myers Squibb Company (USA) Corporation Information
12.12.2 Bristol-Myers Squibb Company (USA) Business Overview
12.12.3 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Products Offered
12.12.5 Bristol-Myers Squibb Company (USA) Recent Development
12.13 Allergan, Inc. (USA)
12.13.1 Allergan, Inc. (USA) Corporation Information
12.13.2 Allergan, Inc. (USA) Business Overview
12.13.3 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Products Offered
12.13.5 Allergan, Inc. (USA) Recent Development
12.14 Novartis AG (Switzerland)
12.14.1 Novartis AG (Switzerland) Corporation Information
12.14.2 Novartis AG (Switzerland) Business Overview
12.14.3 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Products Offered
12.14.5 Novartis AG (Switzerland) Recent Development
12.15 Novo Nordisk A/S (Denmark)
12.15.1 Novo Nordisk A/S (Denmark) Corporation Information
12.15.2 Novo Nordisk A/S (Denmark) Business Overview
12.15.3 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Products Offered
12.15.5 Novo Nordisk A/S (Denmark) Recent Development
12.16 Pfizer, Inc. (USA)
12.16.1 Pfizer, Inc. (USA) Corporation Information
12.16.2 Pfizer, Inc. (USA) Business Overview
12.16.3 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Products Offered
12.16.5 Pfizer, Inc. (USA) Recent Development
12.17 Sanofi S.A (France)
12.17.1 Sanofi S.A (France) Corporation Information
12.17.2 Sanofi S.A (France) Business Overview
12.17.3 Sanofi S.A (France) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Sanofi S.A (France) Pediatric Drugs and Vaccines Products Offered
12.17.5 Sanofi S.A (France) Recent Development
12.18 Shionogi Inc. (USA)
12.18.1 Shionogi Inc. (USA) Corporation Information
12.18.2 Shionogi Inc. (USA) Business Overview
12.18.3 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Products Offered
12.18.5 Shionogi Inc. (USA) Recent Development
12.19 Takeda
12.19.1 Takeda Corporation Information
12.19.2 Takeda Business Overview
12.19.3 Takeda Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Takeda Pediatric Drugs and Vaccines Products Offered
12.19.5 Takeda Recent Development
13 Pediatric Drugs and Vaccines Manufacturing Cost Analysis
13.1 Pediatric Drugs and Vaccines Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Pediatric Drugs and Vaccines
13.4 Pediatric Drugs and Vaccines Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Pediatric Drugs and Vaccines Distributors List
14.3 Pediatric Drugs and Vaccines Customers
15 Market Dynamics
15.1 Pediatric Drugs and Vaccines Market Trends
15.2 Pediatric Drugs and Vaccines Drivers
15.3 Pediatric Drugs and Vaccines Market Challenges
15.4 Pediatric Drugs and Vaccines Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
